Drug Shortage Report for CLONAZEPAM
| Report ID | 13141 |
| Drug Identification Number | 02442035 |
| Brand name | CLONAZEPAM |
| Common or Proper name | CLONAZEPAM |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLONAZEPAM |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AE |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2017-06-16 |
| Actual start date | |
| Estimated end date | 2017-06-26 |
| Actual end date | 2017-07-23 |
| Shortage status | Resolved |
| Updated date | 2017-11-06 |
| Company comments | Alternate Sivem pack size available (500s) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-11-06 | French | Compare |
| v6 | 2017-11-06 | English | Compare |
| v5 | 2017-06-17 | English | Compare |
| v4 | 2017-06-16 | French | Compare |
| v3 | 2017-06-16 | English | Compare |
| v2 | 2017-06-16 | French | Compare |
| v1 | 2017-06-16 | English | Compare |
Showing 1 to 7 of 7